Tokyo, Sept. 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063093) titled 'Development of a feasible methodology for co-production personalized newborn skin care plans' on Sept. 29.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control

Primary Sponsor: Institute - The University of Tokyo

Condition: Condition - Healthy infants Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - In this study, we will develop a communication tool to facilitate discussions between parents and healthcare professionals regarding infants' skincare, taking into account differences in infants' skin conditions, allergic factors, environmental conditions, and skincare habits in various regions and households. We will then implement a program for creating skincare plans using this tool and evaluate parents' confidence in childcare, their adherence to the skincare regimen, and the infants' skin conditions to assess the tool's practicality. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - A program using a co-production personalized newborn skin care plans

Eligibility: Age-lower limit - 1 months-old = Gender - Male and Female Key inclusion criteria - Infants under 6 months of age and their parents Key exclusion criteria - Parent(s) who are unable to visit the study site. Parent(s) with difficulty reading, writing, or communicating in Japanese.

Infants diagnosed with and currently receiving treatment for congenital skin disorders or atopic dermatitis. Target Size - 30

Recruitment Status: Recruitment status - Open public recruiting Date of protocol fixation - 2026 Year 09 Month 28 Day Date of IRB - 2026 Year 08 Month 26 Day Anticipated trial start date - 2026 Year 09 Month 29 Day Last follow-up date - 2026 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072221

Disclaimer: Curated by HT Syndication.